The impact of the novel EUS scope and ultrasonographic system for diagnosis and therapy in patients with pancreatobiliary diseases (videos)
Journal of Hepato-Biliary-Pancreatic Sciences · 2025
DOI: 10.1002/jhbp.12144 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Hiroyuki Kojima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Endosonography, Pancreatic Diseases, Pancreatic Neoplasms, Biliary Tract Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
We evaluated the diagnostic and therapeutic capabilities of endoscopic ultrasonography (EUS) in pancreaticobiliary diseases. We aimed to validate the efficiency of detective flow imaging (DFI), shear wave elastography (SWE), and other advanced imaging techniques.
Methods
We used new EUS scopes (EG‐740 UT and G‐580UR) and the latest ultrasound equipment (ARIETTA 850) (Fujifilm Healthcare, Kanagawa, Japan). Diagnostic procedures were performed in 16 cases, including pancreatic cancer and intraductal papillary mucinous neoplasms, and therapeutic procedures in eight cases, involving complex biliary and pancreatic interventions. The utility of SWE in assessing tissue stiffness was quantified by measuring the shear wave velocity (SWV) in pancreatic cancer and autoimmune pancreatitis.
Results
We found no significant difference in SWVs among different pancreatic conditions; however, significant variations were observed in the net percentage of effective SWV. Interventional EUS had a 100% technical and clinical success rate, demonstrating the efficacy of new imaging techniques and equipment in enhancing procedural safety and diagnostic accuracy.
Conclusions
The integration of advanced EUS imaging technologies, particularly DFI, contrast‐enhanced EUS, and SWE, significantly enhances the diagnosis and treatment of pancreaticobiliary diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
- Department of Clinical Oncology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Hiroyuki Kojima, Takayoshi Tsuchiya, Ryosuke Tonozuka, Shuntaro Mukai, Kenjiro Yamamoto
Zitieren
APA
Kojima, H., Itoi, T., Sofuni, A., Tsuchiya, T., Tanaka, R., Tonozuka, R., Mukai, S., Yamamoto, K., Matsunami, Y., & Minami, H. (2025). The impact of the novel EUS scope and ultrasonographic system for diagnosis and therapy in patients with pancreatobiliary diseases (videos). Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12144
Vancouver
Kojima H, Itoi T, Sofuni A, Tsuchiya T, Tanaka R, Tonozuka R, et al. The impact of the novel EUS scope and ultrasonographic system for diagnosis and therapy in patients with pancreatobiliary diseases (videos). Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12144
BibTeX
@article{Kojima2025,
author = {Kojima, Hiroyuki and Itoi, Takao and Sofuni, Atsushi and Tsuchiya, Takayoshi and Tanaka, Reina and Tonozuka, Ryosuke and Mukai, Shuntaro and Yamamoto, Kenjiro and Matsunami, Yukitoshi and Minami, Hirohito},
title = {The impact of the novel EUS scope and ultrasonographic system for diagnosis and therapy in patients with pancreatobiliary diseases (videos)},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2025},
doi = {10.1002/jhbp.12144}
}
EUVIMED